Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
49
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| DOUGHERTY MICHAEL R | Director | 19 | $101.2K | $0 | 2023-01-11 |
| Lim Bryant David | SVP and General Counsel | 20 | $12.2K | $29.0K | 2023-01-06 |
| Kirby John J. | VP of Finance | 19 | $6.2K | $22.6K | 2023-01-06 |
| JORDAN ANDREW R | Chief Strategy Officer | 4 | $0 | $0 | 2023-01-06 |
| NQ POF V GP, Ltd. | Director | 4 | $0 | $0 | 2022-09-28 |
| Taylor John Clayton | Chief Executive Officer | 2 | $0 | $0 | 2022-09-28 |
| Kraus Carl N | Chief Medical Officer | 3 | $0 | $0 | 2022-09-28 |
| Salain Daniel | Chief Operating Officer | 2 | $0 | $0 | 2022-09-28 |
| WOOTEN RONALD J | Director | 4 | $0 | $0 | 2022-09-28 |
| ZEIN YOUSSEF EL | Director, 10% Owner | 75 | $10.8K | $368.0K | 2022-09-22 |
| SOLAND DANIEL B | Chief Operating Officer | 7 | $98.5K | $0 | 2022-07-06 |
| MILANO VINCENT | President and CEO | 26 | $977.9K | $195.5K | 2022-07-06 |
| Goldberg Mark Alan | Director | 17 | $31.9K | $0 | 2022-06-23 |
| Csimma Cristina | Director | 5 | $0 | $0 | 2022-06-23 |
| GOWEN MAXINE | Director | 11 | $10.5K | $0 | 2022-06-23 |
| SCHAFER CAROL | Director | 14 | $16.6K | $0 | 2022-06-23 |
| GERAGHTY JAMES A | Director | 28 | $843.5K | $0 | 2022-06-23 |
| Pillar Invest Corp | Director, 10% Owner | 38 | $0 | $4.91M | 2021-04-01 |
| Umari Abude | 10% Owner | 13 | $127.3K | $3.06M | 2021-03-26 |
| Tarka Elizabeth Ann | Chief Medical Officer | 7 | $0 | $14.1K | 2021-03-25 |
| PIEN HOWARD H | Director | 11 | $0 | $0 | 2020-10-01 |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | 13 | $0 | $5.7K | 2020-07-21 |
| Pillar Partners Foundation, L.P. | 10% Owner | 6 | $5.91M | $0 | 2020-07-13 |
| Pillar Pharmaceuticals III, L.P. | 10% Owner | 4 | $0 | $559.0K | 2020-01-29 |
| YINGLING JONATHAN MICHAEL | SVP, Early Development | 11 | $0 | $6.2K | 2020-01-10 |
| Pillar Pharmaceuticals 6, L.P. | 10% Owner | 3 | $0 | $296.5K | 2019-11-08 |
| Horobin Joanna | SVP and Chief Medical Officer | 9 | $1.0K | $0 | 2019-07-09 |
| BAKER JULIAN | Director | 15 | $0 | $0 | 2019-07-01 |
| BAKER FELIX | Director, 10% Owner | 24 | $0 | $0 | 2019-06-06 |
| 667, L.P. | Director, 10% Owner | 20 | $6.50M | $0 | 2019-04-01 |
| 14159, L.P. | Director, 10% Owner | 11 | $0 | $0 | 2019-01-02 |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 6 | $0 | $0 | 2018-10-01 |
| Arcudi III Louis J | Chief Financial Officer | 9 | $0 | $0 | 2018-08-13 |
| Pillar Pharmaceuticals II, L.P. | Director, 10% Owner | 30 | $0 | $9.65M | 2018-08-09 |
| Baker Brothers Life Sciences LP | Director, 10% Owner | 14 | $32.00M | $0 | 2018-07-02 |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | 4 | $0 | $0 | 2018-06-20 |
| REARDON WILLIAM S | Director | 12 | $24.7K | $0 | 2018-06-20 |
| Casey Mark J | Senior VP and General Counsel | 6 | $49.6K | $0 | 2018-01-03 |
| AGRAWAL SUDHIR | President of Research | 12 | $0 | $0 | 2017-01-03 |
| Slater Eve Elizabeth | Director | 5 | $0 | $0 | 2015-06-08 |
| Wolf John Peter III | General Counsel | 1 | $0 | $0 | 2014-12-10 |
| BRENNER LOUIS MD | Chief Medical Officer | 2 | $0 | $0 | 2014-12-10 |
| MacCoss Malcolm | Director | 6 | $0 | $0 | 2014-07-01 |
| KARR ROBERT W | Director | 5 | $10.1K | $0 | 2014-06-09 |
| Sullivan Timothy M | VP Development Programs | 9 | $0 | $438.4K | 2014-05-27 |
| Abdul-Wahab Umari | Director | 26 | $0 | $0 | 2014-05-23 |
| Arbeit Robert D. | VP Clinical Development | 4 | $0 | $0 | 2013-12-10 |
| HARTLEY C KEITH | Director | 5 | $45.0K | $0 | 2013-08-16 |
| Senator Investment Group LP | 10% Owner | 12 | $0 | $997.0K | 2012-04-23 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| DOUGHERTY MICHAEL R | Director | A Award | 2023-01-11 | 2023-01-12 | 33,523 | $0.44 | $14.8K | 375,155 | SEC↗ |
| Kirby John J. | CHIEF FINANCIAL OFFICER | F Tax w/h | 2023-01-06 | 2023-01-10 | 119,957 | $0.71 | $85.2K | 316,893 | SEC↗ |
| Kirby John J. | CHIEF FINANCIAL OFFICER | A Award | 2023-01-06 | 2023-01-10 | 399,218 | — | $0 | 436,850 | SEC↗ |
| Lim Bryant David | SVP AND GENERAL COUNSEL | F Tax w/h | 2023-01-06 | 2023-01-10 | 119,957 | $0.71 | $85.2K | 309,695 | SEC↗ |
| Lim Bryant David | SVP AND GENERAL COUNSEL | A Award | 2023-01-06 | 2023-01-10 | 399,218 | — | $0 | 429,652 | SEC↗ |
| JORDAN ANDREW R | CHIEF STRATEGY OFFICER | A Award | 2023-01-06 | 2023-01-10 | 261,718 | — | $0 | 913,082 | SEC↗ |
| JORDAN ANDREW R | CHIEF STRATEGY OFFICER | F Tax w/h | 2023-01-06 | 2023-01-10 | 73,940 | $0.71 | $52.5K | 839,142 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2022-10-03 | 2022-10-05 | 58,516 | $0.37 | $21.7K | 341,632 | SEC↗ |
| NQ POF V GP, Ltd. | Director | J Other deriv | 2022-09-28 | 2022-10-03 | 1,343,547 | — | $0 | 1,343,547 | SEC↗ |
| NQ POF V GP, Ltd. | Director | J Other deriv | 2022-09-28 | 2022-10-03 | 14,115 | — | $0 | 14,115 | SEC↗ |
| NQ POF V GP, Ltd. | Director | J Other deriv | 2022-09-28 | 2022-10-03 | 14,115 | — | $0 | 14,115 | SEC↗ |
| NQ POF V GP, Ltd. | Director | J Other | 2022-09-28 | 2022-10-03 | 5 | — | $0 | 5 | SEC↗ |
| JORDAN ANDREW R | Chief Strategy Officer | A Award deriv | 2022-09-28 | 2022-09-30 | 6,843 | — | $0 | 6,843 | SEC↗ |
| Kraus Carl N | Chief Medical Officer | A Award deriv | 2022-09-28 | 2022-09-30 | 6,843 | — | $0 | 6,843 | SEC↗ |
| Kraus Carl N | Chief Medical Officer | A Award deriv | 2022-09-28 | 2022-09-30 | 6,843 | — | $0 | 6,843 | SEC↗ |
| Kraus Carl N | Chief Medical Officer | A Award deriv | 2022-09-28 | 2022-09-30 | 651,364 | — | $0 | 651,364 | SEC↗ |
| Salain Daniel | Chief Operating Officer | A Award deriv | 2022-09-28 | 2022-09-30 | 22,810 | — | $0 | 22,810 | SEC↗ |
| Taylor John Clayton | Chief Executive Officer | A Award deriv | 2022-09-28 | 2022-09-30 | 22,810 | — | $0 | 22,810 | SEC↗ |
| WOOTEN RONALD J | Director | J Other deriv | 2022-09-28 | 2022-09-30 | 14,115 | — | $0 | 14,115 | SEC↗ |
| WOOTEN RONALD J | Director | J Other deriv | 2022-09-28 | 2022-09-30 | 1,343,547 | — | $0 | 1,343,547 | SEC↗ |
| WOOTEN RONALD J | Director | J Other deriv | 2022-09-28 | 2022-09-30 | 14,115 | — | $0 | 14,115 | SEC↗ |
| JORDAN ANDREW R | Chief Strategy Officer | A Award | 2022-09-28 | 2022-09-30 | 651,364 | — | $0 | 651,364 | SEC↗ |
| Salain Daniel | Chief Operating Officer | A Award | 2022-09-28 | 2022-09-30 | 2,171,214 | — | $0 | 2,171,214 | SEC↗ |
| Taylor John Clayton | Chief Executive Officer | A Award | 2022-09-28 | 2022-09-30 | 2,171,214 | — | $0 | 2,171,214 | SEC↗ |
| WOOTEN RONALD J | Director | J Other | 2022-09-28 | 2022-09-30 | 5 | — | $0 | 5 | SEC↗ |
| ZEIN YOUSSEF EL | 10% Owner | X Exercise deriv | 2022-09-22 | 2022-09-26 | 1,533,159 | — | $0 | 1,533,159 | SEC↗ |
| ZEIN YOUSSEF EL | 10% Owner | X Exercise | 2022-09-22 | 2022-09-26 | 1,533,159 | $0.01 | $15.3K | 7,266,954 | SEC↗ |
| Kirby John J. | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-07-06 | 2022-07-07 | 66,500 | — | $0 | 66,500 | SEC↗ |
| MILANO VINCENT | PRESIDENT AND CEO | A Award deriv | 2022-07-06 | 2022-07-07 | 124,000 | — | $0 | 124,000 | SEC↗ |
| SOLAND DANIEL B | CHIEF OPERATING OFFICER | A Award deriv | 2022-07-06 | 2022-07-07 | 66,500 | — | $0 | 66,500 | SEC↗ |
| Lim Bryant David | SVP AND GENERAL COUNSEL | A Award deriv | 2022-07-06 | 2022-07-07 | 66,500 | — | $0 | 66,500 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2022-07-01 | 2022-07-06 | 50,086 | $0.44 | $22.0K | 283,116 | SEC↗ |
| SCHAFER CAROL | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 26,000 | — | $0 | 26,000 | SEC↗ |
| Csimma Cristina | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 26,000 | — | $0 | 26,000 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 26,000 | — | $0 | 26,000 | SEC↗ |
| Goldberg Mark Alan | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 26,000 | — | $0 | 26,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 26,000 | — | $0 | 26,000 | SEC↗ |
| GOWEN MAXINE | Director | A Award deriv | 2022-06-23 | 2022-06-27 | 26,000 | — | $0 | 26,000 | SEC↗ |
| MILANO VINCENT | PRESIDENT AND CEO | A Award deriv | 2022-04-01 | 2022-04-04 | 99,000 | — | $0 | 99,000 | SEC↗ |
| SOLAND DANIEL B | CHIEF OPERATING OFFICER | A Award deriv | 2022-04-01 | 2022-04-04 | 41,500 | — | $0 | 41,500 | SEC↗ |
| Lim Bryant David | SVP AND GENERAL COUNSEL | A Award deriv | 2022-04-01 | 2022-04-04 | 41,500 | — | $0 | 41,500 | SEC↗ |
| Kirby John J. | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-04-01 | 2022-04-04 | 41,500 | — | $0 | 41,500 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2022-04-01 | 2022-04-05 | 41,155 | $0.54 | $22.2K | 233,030 | SEC↗ |
| MILANO VINCENT | PRESIDENT AND CEO | A Award deriv | 2022-01-24 | 2022-01-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kirby John J. | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-01-24 | 2022-01-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SOLAND DANIEL B | CHIEF OPERATING OFFICER | A Award deriv | 2022-01-24 | 2022-01-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lim Bryant David | SVP AND GENERAL COUNSEL | A Award deriv | 2022-01-24 | 2022-01-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2022-01-03 | 2022-01-05 | 37,062 | $0.59 | $21.9K | 191,875 | SEC↗ |
| Kirby John J. | CHIEF FINANCIAL OFFICER | P Buy | 2021-12-17 | 2021-12-21 | 10,000 | $0.62 | $6.2K | 37,632 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2021-10-04 | 2021-10-04 | 21,229 | $1.03 | $21.9K | 154,813 | SEC↗ |
| Kirby John J. | CHIEF FINANCIAL OFFICER | A Award deriv | 2021-07-08 | 2021-07-12 | 66,500 | — | $0 | 66,500 | SEC↗ |
| Lim Bryant David | SVP AND GENERAL COUNSEL | A Award deriv | 2021-07-08 | 2021-07-12 | 66,500 | — | $0 | 66,500 | SEC↗ |
| SOLAND DANIEL B | CHIEF OPERATING OFFICER | A Award deriv | 2021-07-08 | 2021-07-12 | 66,500 | — | $0 | 66,500 | SEC↗ |
| MILANO VINCENT | PRESIDENT AND CEO | A Award deriv | 2021-07-08 | 2021-07-12 | 124,000 | — | $0 | 124,000 | SEC↗ |
| SOLAND DANIEL B | CHIEF OPERATING OFFICER | P Buy | 2021-06-18 | 2021-06-21 | 50,000 | $1.19 | $59.5K | 78,843 | SEC↗ |
| SCHAFER CAROL | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 26,000 | — | $0 | 26,000 | SEC↗ |
| Csimma Cristina | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 26,000 | — | $0 | 26,000 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 26,000 | — | $0 | 26,000 | SEC↗ |
| Goldberg Mark Alan | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 26,000 | — | $0 | 26,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 26,000 | — | $0 | 26,000 | SEC↗ |
| GOWEN MAXINE | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 26,000 | — | $0 | 26,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | P Buy | 2021-06-01 | 2021-06-03 | 85,000 | $1.19 | $101.2K | 133,584 | SEC↗ |
| Pillar Invest Corp | 10% Owner | X Exercise deriv | 2021-04-01 | 2021-04-29 | 1,612,196 | $0.01 | $16.1K | 1,612,196 | SEC↗ |
| Pillar Invest Corp | 10% Owner | X Exercise deriv | 2021-04-01 | 2021-04-29 | 883,613 | $0.01 | $8.8K | 883,613 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2021-04-01 | 2021-04-05 | 10,939 | $1.32 | $14.4K | 48,584 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award | 2021-04-01 | 2021-04-05 | 14,773 | $1.32 | $19.5K | 119,543 | SEC↗ |
| Goldberg Mark Alan | Director | A Award | 2021-04-01 | 2021-04-05 | 10,511 | $1.32 | $13.9K | 48,610 | SEC↗ |
| SCHAFER CAROL | Director | A Award | 2021-04-01 | 2021-04-05 | 11,177 | $1.32 | $14.8K | 59,665 | SEC↗ |
| Pillar Invest Corp | 10% Owner | X Exercise | 2021-04-01 | 2021-04-29 | 883,613 | $0.01 | $8.8K | 2,304,180 | SEC↗ |
| Pillar Invest Corp | 10% Owner | X Exercise | 2021-04-01 | 2021-04-29 | 1,612,196 | $0.01 | $16.1K | 5,733,795 | SEC↗ |
| Umari Abude | 10% Owner | X Exercise deriv | 2021-03-26 | 2021-03-31 | 884,175 | $0.01 | $8.8K | 884,175 | SEC↗ |
| Umari Abude | 10% Owner | X Exercise deriv | 2021-03-26 | 2021-03-31 | 1,611,634 | $0.01 | $16.1K | 1,611,634 | SEC↗ |
| Umari Abude | 10% Owner | X Exercise | 2021-03-26 | 2021-03-31 | 1,611,634 | $0.01 | $16.1K | 5,733,233 | SEC↗ |
| Umari Abude | 10% Owner | X Exercise | 2021-03-26 | 2021-03-31 | 884,175 | $0.01 | $8.8K | 2,492,342 | SEC↗ |
| Kirby John J. | CHIEF FINANCIAL OFFICER | S Sale | 2021-03-25 | 2021-03-29 | 6,250 | $1.42 | $8.9K | 27,632 | SEC↗ |
| Lim Bryant David | SVP AND GENERAL COUNSEL | S Sale | 2021-03-25 | 2021-03-29 | 7,630 | $1.36 | $10.4K | 30,434 | SEC↗ |
| Tarka Elizabeth Ann | CHIEF MEDICAL OFFICER | S Sale | 2021-03-25 | 2021-03-29 | 5,018 | $1.35 | $6.8K | 13,237 | SEC↗ |
| Umari Abude | 10% Owner | S Sale | 2021-03-18 | 2021-03-31 | 1,376,039 | $1.80 | $2.48M | 4,121,599 | SEC↗ |
| Umari Abude | 10% Owner | S Sale | 2021-03-18 | 2021-03-31 | 323,726 | $1.80 | $582.7K | 1,608,167 | SEC↗ |
| SOLAND DANIEL B | CHIEF OPERATING OFFICER | P Buy | 2021-03-05 | 2021-03-05 | 10,000 | $3.90 | $39.0K | 28,843 | SEC↗ |
| Umari Abude | 10% Owner | X Exercise deriv | 2021-01-20 | 2021-03-31 | 643,525 | $0.01 | $6.4K | 643,525 | SEC↗ |
| Umari Abude | 10% Owner | X Exercise | 2021-01-20 | 2021-03-31 | 643,525 | $0.01 | $6.4K | 1,931,893 | SEC↗ |
| MILANO VINCENT | President & CEO | S Sale | 2021-01-12 | 2021-01-12 | 3,210 | $4.20 | $13.5K | 208,611 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | S Sale | 2021-01-12 | 2021-01-12 | 1,711 | $4.21 | $7.2K | 38,064 | SEC↗ |
| Tarka Elizabeth Ann | Chief Medical Officer | S Sale | 2021-01-12 | 2021-01-12 | 1,745 | $4.19 | $7.3K | 18,255 | SEC↗ |
| Kirby John J. | Chief Financial Officer | S Sale | 2021-01-12 | 2021-01-12 | 1,693 | $4.22 | $7.1K | 33,882 | SEC↗ |
| MILANO VINCENT | President & CEO | A Award deriv | 2021-01-08 | 2021-01-12 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | A Award deriv | 2021-01-08 | 2021-01-12 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Tarka Elizabeth Ann | Chief Medical Officer | A Award deriv | 2021-01-08 | 2021-01-12 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Kirby John J. | Chief Financial Officer | A Award deriv | 2021-01-08 | 2021-01-12 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Kirby John J. | Chief Financial Officer | S Sale | 2021-01-05 | 2021-01-06 | 862 | $3.90 | $3.4K | 35,575 | SEC↗ |
| MILANO VINCENT | President & CEO | S Sale | 2021-01-05 | 2021-01-11 | 2,740 | $3.91 | $10.7K | 211,821 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | S Sale | 2021-01-05 | 2021-01-11 | 1,465 | $3.91 | $5.7K | 39,775 | SEC↗ |
| SOLAND DANIEL B | Chief Operating Officer | A Award deriv | 2021-01-04 | 2021-01-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2021-01-04 | 2021-01-06 | 3,515 | $4.02 | $14.1K | 37,645 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award | 2021-01-04 | 2021-01-06 | 4,851 | $4.02 | $19.5K | 104,770 | SEC↗ |
| Goldberg Mark Alan | Director | A Award | 2021-01-04 | 2021-01-06 | 3,452 | $4.02 | $13.9K | 38,099 | SEC↗ |
| SCHAFER CAROL | Director | A Award | 2021-01-04 | 2021-01-06 | 3,620 | $4.02 | $14.6K | 48,488 | SEC↗ |
| MILANO VINCENT | President & CEO | S Sale | 2020-12-22 | 2020-12-22 | 37,169 | $4.32 | $160.6K | 214,561 | SEC↗ |
| MILANO VINCENT | President & CEO | A Award | 2020-12-18 | 2020-12-22 | 128,170 | — | $0 | 251,730 | SEC↗ |
| Umari Abude | 10% Owner | P Buy deriv | 2020-12-11 | 2020-12-15 | 766,941 | — | $0 | 766,941 | SEC↗ |
| Umari Abude | 10% Owner | P Buy deriv | 2020-12-11 | 2020-12-15 | 1,143,428 | — | $0 | 1,143,428 | SEC↗ |
| Umari Abude | 10% Owner | P Buy deriv | 2020-12-11 | 2020-12-15 | 1,533,883 | — | $0 | 1,533,883 | SEC↗ |
| Umari Abude | 10% Owner | P Buy deriv | 2020-12-11 | 2020-12-15 | 606,885 | — | $0 | 606,885 | SEC↗ |
| Umari Abude | 10% Owner | P Buy | 2020-12-11 | 2020-12-15 | 69,941 | $1.82 | $127.3K | 5,497,638 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2020-10-01 | 2020-10-05 | 5,722 | $2.25 | $12.9K | 34,130 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award | 2020-10-01 | 2020-10-05 | 8,666 | $2.25 | $19.5K | 99,919 | SEC↗ |
| Goldberg Mark Alan | Director | A Award | 2020-10-01 | 2020-10-05 | 6,166 | $2.25 | $13.9K | 34,647 | SEC↗ |
| PIEN HOWARD H | Director | A Award | 2020-10-01 | 2020-10-05 | 5,583 | $2.25 | $12.6K | 45,457 | SEC↗ |
| SCHAFER CAROL | Director | A Award | 2020-10-01 | 2020-10-05 | 6,111 | $2.25 | $13.7K | 44,868 | SEC↗ |
| MILANO VINCENT | President & CEO | A Award deriv | 2020-07-21 | 2020-07-23 | 92,000 | — | $0 | 92,000 | SEC↗ |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | A Award deriv | 2020-07-21 | 2020-07-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Kirby John J. | Chief Financial Officer | A Award deriv | 2020-07-21 | 2020-07-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | A Award deriv | 2020-07-21 | 2020-07-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Tarka Elizabeth Ann | Chief Medical Officer | A Award deriv | 2020-07-21 | 2020-07-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Pillar Partners Foundation, L. | 10% Owner | P Buy deriv | 2020-07-13 | 2020-07-15 | 2,014,234 | — | $0 | 2,014,234 | SEC↗ |
| Pillar Partners Foundation, L. | 10% Owner | P Buy deriv | 2020-07-13 | 2020-07-15 | 2,764,227 | — | $0 | 2,764,227 | SEC↗ |
| Pillar Partners Foundation, L. | 10% Owner | P Buy | 2020-07-13 | 2020-07-15 | 749,993 | $1.72 | $1.29M | 5,427,697 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2020-07-01 | 2020-07-02 | 7,193 | $1.79 | $12.9K | 28,408 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award | 2020-07-01 | 2020-07-02 | 10,894 | $1.79 | $19.5K | 91,253 | SEC↗ |
| Goldberg Mark Alan | Director | A Award | 2020-07-01 | 2020-07-02 | 7,751 | $1.79 | $13.9K | 28,481 | SEC↗ |
| PIEN HOWARD H | Director | A Award | 2020-07-01 | 2020-07-02 | 7,018 | $1.79 | $12.6K | 39,874 | SEC↗ |
| SCHAFER CAROL | Director | A Award | 2020-07-01 | 2020-07-02 | 7,681 | $1.79 | $13.7K | 38,757 | SEC↗ |
| ZEIN YOUSSEF EL | 10% Owner | P Buy deriv | 2020-05-12 | 2020-09-04 | 3,039,514 | — | $0 | 3,039,514 | SEC↗ |
| Csimma Cristina | Director | A Award deriv | 2020-05-12 | 2020-05-19 | 11,500 | — | $0 | 11,500 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2020-05-12 | 2020-05-19 | 11,500 | — | $0 | 11,500 | SEC↗ |
| Goldberg Mark Alan | Director | A Award deriv | 2020-05-12 | 2020-05-19 | 11,500 | — | $0 | 11,500 | SEC↗ |
| GOWEN MAXINE | Director | A Award deriv | 2020-05-12 | 2020-05-19 | 11,500 | — | $0 | 11,500 | SEC↗ |
| PIEN HOWARD H | Director | A Award deriv | 2020-05-12 | 2020-05-19 | 11,500 | — | $0 | 11,500 | SEC↗ |
| SCHAFER CAROL | Director | A Award deriv | 2020-05-12 | 2020-05-19 | 11,500 | — | $0 | 11,500 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award deriv | 2020-05-12 | 2020-05-19 | 14,500 | — | $0 | 14,500 | SEC↗ |
| Pillar Partners Foundation, L. | 10% Owner | J Other | 2020-04-17 | 2020-09-04 | 46,304 | — | $0 | 5,427,697 | SEC↗ |
| Pillar Partners Foundation, L. | 10% Owner | J Other | 2020-04-17 | 2020-09-04 | 103,891 | — | $0 | 1,288,368 | SEC↗ |
| Pillar Partners Foundation, L. | 10% Owner | P Buy | 2020-04-07 | 2020-04-09 | 3,039,514 | $1.52 | $4.62M | 6,260,832 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2020-04-01 | 2020-04-03 | 10,059 | $1.28 | $12.9K | 21,215 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award | 2020-04-01 | 2020-04-03 | 14,926 | $1.28 | $19.1K | 80,359 | SEC↗ |
| Goldberg Mark Alan | Director | A Award | 2020-04-01 | 2020-04-03 | 10,730 | $1.28 | $13.7K | 20,730 | SEC↗ |
| PIEN HOWARD H | Director | A Award | 2020-04-01 | 2020-04-03 | 9,666 | $1.28 | $12.4K | 32,856 | SEC↗ |
| SCHAFER CAROL | Director | A Award | 2020-04-01 | 2020-04-03 | 10,633 | $1.28 | $13.6K | 31,076 | SEC↗ |
| Pillar Pharmaceuticals III, L. | 10% Owner | S Sale | 2020-01-29 | 2020-02-26 | 17,250 | $1.76 | $30.4K | 3,254,442 | SEC↗ |
| Pillar Pharmaceuticals III, L. | 10% Owner | S Sale | 2020-01-28 | 2020-02-26 | 12,532 | $1.76 | $22.1K | 3,271,692 | SEC↗ |
| Pillar Pharmaceuticals III, L. | 10% Owner | S Sale | 2020-01-27 | 2020-02-26 | 15,000 | $1.77 | $26.6K | 3,284,224 | SEC↗ |
| MILANO VINCENT | President & CEO | A Award deriv | 2020-01-10 | 2020-01-14 | 92,000 | — | $0 | 92,000 | SEC↗ |
| Kirby John J. | Chief Financial Officer | A Award deriv | 2020-01-10 | 2020-01-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | A Award deriv | 2020-01-10 | 2020-01-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | A Award deriv | 2020-01-10 | 2020-01-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Tarka Elizabeth Ann | Chief Medical Officer | A Award deriv | 2020-01-10 | 2020-01-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| YINGLING JONATHAN MICHAEL | Chief Scientific Officer | A Award deriv | 2020-01-10 | 2020-01-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MILANO VINCENT | President & CEO | A Award | 2020-01-10 | 2020-01-14 | 37,000 | — | $0 | 123,560 | SEC↗ |
| Kirby John J. | Chief Financial Officer | A Award | 2020-01-10 | 2020-01-14 | 20,000 | — | $0 | 36,437 | SEC↗ |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | A Award | 2020-01-10 | 2020-01-14 | 20,000 | — | $0 | 36,485 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | A Award | 2020-01-10 | 2020-01-14 | 20,000 | — | $0 | 41,240 | SEC↗ |
| Tarka Elizabeth Ann | Chief Medical Officer | A Award | 2020-01-10 | 2020-01-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| YINGLING JONATHAN MICHAEL | Chief Scientific Officer | A Award | 2020-01-10 | 2020-01-14 | 20,000 | — | $0 | 36,358 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | S Sale | 2020-01-07 | 2020-01-10 | 1,603 | $1.78 | $2.9K | 21,240 | SEC↗ |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | S Sale | 2020-01-07 | 2020-01-10 | 1,615 | $1.78 | $2.9K | 16,485 | SEC↗ |
| Kirby John J. | Chief Financial Officer | S Sale | 2020-01-07 | 2020-01-10 | 911 | $1.78 | $1.6K | 16,437 | SEC↗ |
| MILANO VINCENT | President & CEO | S Sale | 2020-01-07 | 2020-01-10 | 3,006 | $1.78 | $5.4K | 86,560 | SEC↗ |
| YINGLING JONATHAN MICHAEL | Chief Scientific Officer | S Sale | 2020-01-07 | 2020-01-10 | 1,742 | $1.78 | $3.1K | 16,358 | SEC↗ |
| MILANO VINCENT | President & CEO | S Sale | 2020-01-07 | 2020-01-14 | 3,006 | $1.78 | $5.4K | 86,560 | SEC↗ |
| Kirby John J. | Chief Financial Officer | S Sale | 2020-01-07 | 2020-01-14 | 911 | $1.78 | $1.6K | 16,437 | SEC↗ |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | S Sale | 2020-01-07 | 2020-01-14 | 1,615 | $1.78 | $2.9K | 16,485 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | S Sale | 2020-01-07 | 2020-01-14 | 1,603 | $1.78 | $2.9K | 21,240 | SEC↗ |
| YINGLING JONATHAN MICHAEL | Chief Scientific Officer | S Sale | 2020-01-07 | 2020-01-14 | 1,742 | $1.78 | $3.1K | 16,358 | SEC↗ |
| PIEN HOWARD H | Director | A Award | 2020-01-02 | 2020-01-06 | 6,790 | $1.85 | $12.6K | 23,190 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2020-01-02 | 2020-01-06 | 7,037 | $1.85 | $13.0K | 11,156 | SEC↗ |
| Pillar Pharmaceuticals 6, L.P. | 10% Owner | S Sale | 2019-11-08 | 2019-11-08 | 9,000 | $2.44 | $22.0K | 3,299,224 | SEC↗ |
| Pillar Pharmaceuticals 6, L.P. | 10% Owner | S Sale | 2019-11-07 | 2019-11-08 | 10,000 | $2.45 | $24.5K | 3,308,224 | SEC↗ |
| Pillar Pharmaceuticals 6, L.P. | 10% Owner | S Sale | 2019-11-06 | 2019-11-08 | 100,000 | $2.50 | $250.0K | 3,318,224 | SEC↗ |
| SCHAFER CAROL | Director | A Award | 2019-10-01 | 2019-10-02 | 5,098 | $2.67 | $13.6K | 20,443 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award | 2019-10-01 | 2019-10-02 | 4,119 | $2.67 | $11.0K | 4,119 | SEC↗ |
| PIEN HOWARD H | Director | A Award | 2019-10-01 | 2019-10-02 | 4,610 | $2.67 | $12.3K | 16,400 | SEC↗ |
| Tarka Elizabeth Ann | Chief Medical Officer | A Award deriv | 2019-07-22 | 2019-07-23 | 130,000 | — | $0 | 130,000 | SEC↗ |
| MILANO VINCENT | President & CEO | A Award deriv | 2019-07-09 | 2019-07-11 | 84,500 | — | $0 | 84,500 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | A Award deriv | 2019-07-09 | 2019-07-11 | 45,500 | — | $0 | 45,500 | SEC↗ |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | A Award deriv | 2019-07-09 | 2019-07-11 | 45,500 | — | $0 | 45,500 | SEC↗ |
| Horobin Joanna | Chief Medical Officer | A Award deriv | 2019-07-09 | 2019-07-11 | 45,500 | — | $0 | 45,500 | SEC↗ |
| Kirby John J. | VP of Finance | A Award deriv | 2019-07-09 | 2019-07-11 | 45,500 | — | $0 | 45,500 | SEC↗ |
| YINGLING JONATHAN MICHAEL | Chief Scientific Officer | A Award deriv | 2019-07-09 | 2019-07-11 | 45,500 | — | $0 | 45,500 | SEC↗ |
| SCHAFER CAROL | Director | A Award | 2019-07-01 | 2019-07-02 | 5,179 | $2.61 | $13.5K | 15,345 | SEC↗ |
| PIEN HOWARD H | Director | A Award | 2019-07-01 | 2019-07-02 | 4,469 | $2.61 | $11.7K | 11,790 | SEC↗ |
| BAKER JULIAN | 10% Owner | A Award | 2019-07-01 | 2019-07-03 | 2,964 | $2.61 | $7.7K | 4,290,995 | SEC↗ |
| BAKER JULIAN | 10% Owner | A Award | 2019-07-01 | 2019-07-03 | 2,964 | $2.61 | $7.7K | 350,721 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other deriv | 2019-06-06 | 2019-06-07 | 880 | — | $0 | 880 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other deriv | 2019-06-06 | 2019-06-07 | 1,660 | — | $0 | 1,660 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other deriv | 2019-06-06 | 2019-06-07 | 6,256 | — | $0 | 6,256 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other deriv | 2019-06-06 | 2019-06-07 | 6,256 | — | $0 | 6,256 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other deriv | 2019-06-06 | 2019-06-07 | 1,660 | — | $0 | 1,660 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other deriv | 2019-06-06 | 2019-06-07 | 880 | — | $0 | 880 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other deriv | 2019-06-06 | 2019-06-07 | 6,009 | — | $0 | 0 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other deriv | 2019-06-06 | 2019-06-07 | 11,337 | — | $0 | 0 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other deriv | 2019-06-06 | 2019-06-07 | 42,724 | — | $0 | 0 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other | 2019-06-06 | 2019-06-07 | 178,967 | — | $0 | 347,757 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other | 2019-06-06 | 2019-06-07 | 21,929 | — | $0 | 21,929 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other | 2019-06-06 | 2019-06-07 | 59,267 | — | $0 | 0 | SEC↗ |
| BAKER FELIX | 10% Owner | J Other | 2019-06-06 | 2019-06-07 | 21,929 | — | $0 | 21,929 | SEC↗ |
| Csimma Cristina | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 11,500 | — | $0 | 11,500 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 11,500 | — | $0 | 11,500 | SEC↗ |
| Goldberg Mark Alan | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 11,500 | — | $0 | 11,500 | SEC↗ |
| GOWEN MAXINE | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 11,500 | — | $0 | 11,500 | SEC↗ |
| PIEN HOWARD H | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 11,500 | — | $0 | 11,500 | SEC↗ |
| SCHAFER CAROL | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 11,500 | — | $0 | 11,500 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award deriv | 2019-06-04 | 2019-06-06 | 14,500 | — | $0 | 14,500 | SEC↗ |
| Csimma Cristina | Director | A Award deriv | 2019-04-08 | 2019-04-10 | 23,000 | — | $0 | 23,000 | SEC↗ |
| DOUGHERTY MICHAEL R | Director | A Award deriv | 2019-04-08 | 2019-04-10 | 23,000 | — | $0 | 23,000 | SEC↗ |
| SCHAFER CAROL | Director | A Award | 2019-04-01 | 2019-04-02 | 5,166 | $2.59 | $13.4K | 10,166 | SEC↗ |
| PIEN HOWARD H | Director | A Award | 2019-04-01 | 2019-04-02 | 4,392 | $2.59 | $11.4K | 7,321 | SEC↗ |
| 667, L.P. | Director, 10% Owner | A Award | 2019-04-01 | 2019-04-03 | 4,161 | $2.59 | $10.8K | 89,233 | SEC↗ |
| 667, L.P. | Director, 10% Owner | A Award | 2019-04-01 | 2019-04-03 | 4,161 | $2.59 | $10.8K | 4,288,031 | SEC↗ |
| 667, L.P. | Director, 10% Owner | A Award | 2019-04-01 | 2019-04-03 | 4,161 | $2.59 | $10.8K | 526,724 | SEC↗ |
| MILANO VINCENT | President & CEO | A Award deriv | 2019-01-03 | 2019-01-07 | 84,500 | — | $0 | 84,500 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | A Award deriv | 2019-01-03 | 2019-01-07 | 45,500 | — | $0 | 45,500 | SEC↗ |
| Kirby John J. | VP of Finance | A Award deriv | 2019-01-03 | 2019-01-07 | 25,600 | — | $0 | 25,600 | SEC↗ |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | A Award deriv | 2019-01-03 | 2019-01-07 | 45,500 | — | $0 | 45,500 | SEC↗ |
| Horobin Joanna | Chief Medical Officer | A Award deriv | 2019-01-03 | 2019-01-07 | 45,500 | — | $0 | 45,500 | SEC↗ |
| YINGLING JONATHAN MICHAEL | Chief Scientific Officer | A Award deriv | 2019-01-03 | 2019-01-07 | 45,500 | — | $0 | 45,500 | SEC↗ |
| MILANO VINCENT | President & CEO | A Award | 2019-01-03 | 2019-01-07 | 33,750 | — | $0 | 89,566 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | A Award | 2019-01-03 | 2019-01-07 | 18,100 | — | $0 | 22,843 | SEC↗ |
| Kirby John J. | VP of Finance | A Award | 2019-01-03 | 2019-01-07 | 10,250 | — | $0 | 12,509 | SEC↗ |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | A Award | 2019-01-03 | 2019-01-07 | 18,100 | — | $0 | 18,100 | SEC↗ |
| Horobin Joanna | Chief Medical Officer | A Award | 2019-01-03 | 2019-01-07 | 18,100 | — | $0 | 20,144 | SEC↗ |
| YINGLING JONATHAN MICHAEL | Chief Scientific Officer | A Award | 2019-01-03 | 2019-01-07 | 18,100 | — | $0 | 18,100 | SEC↗ |
| PIEN HOWARD H | Director | A Award | 2019-01-02 | 2019-01-03 | 2,929 | $3.52 | $10.3K | 2,929 | SEC↗ |
| 14159, L.P. | Director, 10% Owner | A Award | 2019-01-02 | 2019-01-04 | 3,658 | $3.52 | $12.9K | 85,072 | SEC↗ |
| 14159, L.P. | Director, 10% Owner | A Award | 2019-01-02 | 2019-01-04 | 3,658 | $3.52 | $12.9K | 4,283,870 | SEC↗ |
| 14159, L.P. | Director, 10% Owner | A Award | 2019-01-02 | 2019-01-04 | 3,658 | $3.52 | $12.9K | 522,563 | SEC↗ |
| MILANO VINCENT | President & CEO | P Buy | 2018-12-24 | 2018-12-26 | 15,000 | $2.93 | $44.0K | 55,816 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | P Buy | 2018-12-21 | 2018-12-26 | 4,000 | $3.05 | $12.2K | 4,743 | SEC↗ |
| Horobin Joanna | Chief Medical Officer | P Buy | 2018-12-20 | 2018-12-20 | 300 | $3.45 | $1.0K | 2,044 | SEC↗ |
| SCHAFER CAROL | Director | P Buy | 2018-12-19 | 2018-12-20 | 5,000 | $3.33 | $16.6K | 5,000 | SEC↗ |
| Goldberg Mark Alan | Director | P Buy | 2018-12-19 | 2018-12-20 | 10,000 | $3.19 | $31.9K | 10,000 | SEC↗ |
| SCHAFER CAROL | Director | A Award deriv | 2018-12-18 | 2018-12-20 | 23,000 | — | $0 | 23,000 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award | 2018-10-01 | 2018-10-03 | 2,340 | $8.71 | $20.4K | 81,414 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award | 2018-10-01 | 2018-10-03 | 2,340 | $8.71 | $20.4K | 4,280,212 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award | 2018-10-01 | 2018-10-03 | 2,340 | $8.71 | $20.4K | 518,905 | SEC↗ |
| PIEN HOWARD H | Director | A Award deriv | 2018-09-18 | 2018-09-20 | 23,000 | — | $0 | 23,000 | SEC↗ |
| Lim Bryant David | SVP and General Counsel | A Award deriv | 2018-09-10 | 2018-09-13 | 130,000 | — | $0 | 130,000 | SEC↗ |
| YINGLING JONATHAN MICHAEL | Chief Scientific Officer | A Award deriv | 2018-08-13 | 2018-08-15 | 32,500 | — | $0 | 32,500 | SEC↗ |
| Horobin Joanna | Chief Medical Officer | A Award deriv | 2018-08-13 | 2018-08-15 | 32,500 | — | $0 | 32,500 | SEC↗ |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | A Award deriv | 2018-08-13 | 2018-08-15 | 32,500 | — | $0 | 32,500 | SEC↗ |
| Arcudi III Louis J | Chief Financial Officer | A Award deriv | 2018-08-13 | 2018-08-15 | 32,500 | — | $0 | 32,500 | SEC↗ |
| MILANO VINCENT | President & CEO | A Award deriv | 2018-08-13 | 2018-08-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-08-09 | 2018-08-17 | 15,000 | $6.25 | $93.8K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-08-09 | 2018-08-17 | 25,000 | $6.29 | $157.3K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-08-09 | 2018-08-17 | 15,000 | $6.35 | $95.3K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-08-08 | 2018-08-17 | 20,000 | $5.98 | $119.6K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-08-08 | 2018-08-17 | 50,000 | $5.88 | $294.0K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-08-08 | 2018-08-17 | 8,107 | $5.89 | $47.8K | 0 | SEC↗ |
| GERAGHTY JAMES A | Director | P Buy | 2018-08-07 | 2018-08-08 | 10,000 | $5.58 | $55.8K | 65,433 | SEC↗ |
| MILANO VINCENT | President & CEO | P Buy | 2018-08-07 | 2018-08-08 | 10,000 | $5.51 | $55.1K | 40,816 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-08-07 | 2018-08-17 | 91,893 | $5.55 | $510.0K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-08-07 | 2018-08-17 | 75,000 | $5.62 | $421.5K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-07-20 | 2018-07-24 | 492,567 | $0.86 | $423.6K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-07-19 | 2018-07-24 | 556,000 | $0.88 | $489.3K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2018-07-18 | 2018-07-24 | 1,725,000 | $0.85 | $1.47M | 0 | SEC↗ |
| Pillar Invest Corp | 10% Owner | S Sale | 2018-07-17 | 2018-07-19 | 874,505 | $0.99 | $865.8K | 0 | SEC↗ |
| Pillar Invest Corp | 10% Owner | S Sale | 2018-07-16 | 2018-07-19 | 735,771 | $1.01 | $743.1K | 0 | SEC↗ |
| Pillar Invest Corp | 10% Owner | S Sale | 2018-07-13 | 2018-07-19 | 250,500 | $1.05 | $263.0K | 0 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award | 2018-07-02 | 2018-07-05 | 8,096 | $1.32 | $10.7K | 443,465 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | A Award | 2018-07-02 | 2018-07-05 | 16,383 | $1.32 | $21.6K | 34,222,983 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | A Award | 2018-07-02 | 2018-07-05 | 16,383 | $1.32 | $21.6K | 632,599 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | A Award | 2018-07-02 | 2018-07-05 | 16,383 | $1.32 | $21.6K | 4,132,528 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | A Award deriv | 2018-06-20 | 2018-06-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| REARDON WILLIAM S | Director | A Award deriv | 2018-06-20 | 2018-06-22 | 50,000 | $1.53 | $76.5K | 50,000 | SEC↗ |
| GOWEN MAXINE | Director | A Award deriv | 2018-06-20 | 2018-06-22 | 50,000 | $1.53 | $76.5K | 50,000 | SEC↗ |
| Goldberg Mark Alan | Director | A Award deriv | 2018-06-20 | 2018-06-22 | 50,000 | $1.53 | $76.5K | 50,000 | SEC↗ |
| GERAGHTY JAMES A | Director | A Award deriv | 2018-06-20 | 2018-06-22 | 63,000 | $1.53 | $96.4K | 63,000 | SEC↗ |
| Pillar Invest Corp | 10% Owner | X Exercise deriv | 2018-04-25 | 2018-04-27 | 1,200,000 | — | $0 | 0 | SEC↗ |
| Pillar Invest Corp | 10% Owner | X Exercise | 2018-04-25 | 2018-04-27 | 1,200,000 | — | $0 | 0 | SEC↗ |
| 667, L.P. | Director | A Award | 2018-04-02 | 2018-04-04 | 13,349 | $1.62 | $21.6K | 4,116,145 | SEC↗ |
| 667, L.P. | Director | A Award | 2018-04-02 | 2018-04-04 | 13,349 | $1.62 | $21.6K | 34,206,600 | SEC↗ |
| 667, L.P. | Director | A Award | 2018-04-02 | 2018-04-04 | 13,349 | $1.62 | $21.6K | 616,216 | SEC↗ |
| BAKER FELIX | Director, 10% Owner | M Exercise deriv | 2018-03-15 | 2018-03-15 | 17,626,445 | — | $0 | 0 | SEC↗ |
| BAKER FELIX | Director, 10% Owner | M Exercise deriv | 2018-03-15 | 2018-03-15 | 2,250,846 | — | $0 | 0 | SEC↗ |
| BAKER FELIX | Director, 10% Owner | M Exercise deriv | 2018-03-15 | 2018-03-15 | 439,036 | — | $0 | 0 | SEC↗ |
| BAKER FELIX | Director, 10% Owner | M Exercise | 2018-03-15 | 2018-03-15 | 439,036 | $0.47 | $206.3K | 602,867 | SEC↗ |
| BAKER FELIX | Director, 10% Owner | M Exercise | 2018-03-15 | 2018-03-15 | 17,626,445 | $0.47 | $8.28M | 34,193,251 | SEC↗ |
| BAKER FELIX | Director, 10% Owner | M Exercise | 2018-03-15 | 2018-03-15 | 2,250,846 | $0.47 | $1.06M | 4,102,796 | SEC↗ |
| Pillar Pharmaceuticals III, L. | 10% Owner | S Sale | 2018-01-17 | 2018-01-19 | 200,000 | $2.40 | $480.0K | 0 | SEC↗ |
| Casey Mark J | Senior VP & General Counsel | A Award deriv | 2018-01-03 | 2018-01-05 | 270,000 | $2.24 | $604.8K | 270,000 | SEC↗ |
| Arcudi III Louis J | Chief Financial Officer | A Award deriv | 2018-01-03 | 2018-01-05 | 270,000 | $2.24 | $604.8K | 270,000 | SEC↗ |
| Fletcher Robert C. | Sr. VP, Bus. Dev. & Strategy | A Award deriv | 2018-01-03 | 2018-01-05 | 270,000 | $2.24 | $604.8K | 270,000 | SEC↗ |
| Horobin Joanna | Chief Medical Officer | A Award deriv | 2018-01-03 | 2018-01-05 | 270,000 | $2.24 | $604.8K | 270,000 | SEC↗ |
| YINGLING JONATHAN MICHAEL | SVP, Early Development | A Award deriv | 2018-01-03 | 2018-01-05 | 270,000 | $2.24 | $604.8K | 270,000 | SEC↗ |
| MILANO VINCENT | President & CEO | A Award deriv | 2018-01-03 | 2018-01-05 | 600,000 | $2.24 | $1.34M | 600,000 | SEC↗ |
| 667, L.P. | Director | A Award | 2018-01-02 | 2018-01-04 | 9,333 | $2.21 | $20.6K | 16,566,806 | SEC↗ |
| 667, L.P. | Director | A Award | 2018-01-02 | 2018-01-04 | 9,333 | $2.21 | $20.6K | 163,831 | SEC↗ |
| 667, L.P. | Director | A Award | 2018-01-02 | 2018-01-04 | 9,333 | $2.21 | $20.6K | 1,851,950 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2017-12-15 | 2017-12-15 | 33,830 | $1.91 | $64.6K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | X Exercise deriv | 2017-12-14 | 2017-12-15 | 700,000 | — | $0 | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2017-12-14 | 2017-12-15 | 166,170 | $2.01 | $334.0K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | X Exercise | 2017-12-14 | 2017-12-15 | 700,000 | — | $0 | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2017-12-14 | 2017-12-15 | 700,000 | $2.00 | $1.40M | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2017-12-14 | 2017-12-15 | 300,000 | $2.00 | $600.0K | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2017-12-13 | 2017-12-15 | 600,000 | $1.93 | $1.16M | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | 10% Owner | S Sale | 2017-12-13 | 2017-12-15 | 500,000 | $1.92 | $960.0K | 0 | SEC↗ |
| Baker Brothers Life Sciences L | Director | P Buy | 2017-10-26 | 2017-10-30 | 7,204,652 | $1.50 | $10.81M | 16,557,473 | SEC↗ |
| Baker Brothers Life Sciences L | Director | P Buy | 2017-10-26 | 2017-10-30 | 795,348 | $1.50 | $1.19M | 1,842,617 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | Director, 10% Owner | X Exercise deriv | 2017-10-16 | 2017-10-17 | 6,842,844 | — | $0 | 0 | SEC↗ |
| Pillar Pharmaceuticals II, L.P | Director, 10% Owner | X Exercise | 2017-10-16 | 2017-10-17 | 6,842,844 | — | $0 | 0 | SEC↗ |